-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Approaches for Unfit Patients with Aggressive Lymphomas

Program: Education Program
Session: Challenging Situations for Patients with Aggressive Lymphomas
Saturday, December 5, 2020, 11:55 AM-12:00 PM

Nancy Bartlett

Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO

Disclosures: Bartlett: Roche/Genentech: Membership on an entity's Board of Directors or advisory committees, Research Funding; Bristol-Meyers Squibb: Research Funding; BTG: Membership on an entity's Board of Directors or advisory committees; Merck: Research Funding; Kite Pharma: Research Funding; Seattle Genetics: Membership on an entity's Board of Directors or advisory committees, Research Funding; Affimed: Research Funding; ADC Therapeutics: Membership on an entity's Board of Directors or advisory committees, Research Funding; Celgene: Research Funding; Immune Design: Research Funding; Pharmacyclics: Research Funding; Autolus: Research Funding; Janssen: Research Funding; Forty Seven: Research Funding; Pfizer: Research Funding; Millennium: Research Funding.

See more of: Challenging Situations for Patients with Aggressive Lymphomas
See more of: Education Program
Previous Presentation | Next Presentation >>